Integrated Proteins (INTEGFD) | Financial Analysis & Statements
Integrated Proteins Ltd. Small-cap Consumer Defensive
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
0
Gross Profit
0
Operating Income
-472.0K
Net Income
1.0K
EPS (Diluted)
₹0.00
Balance Sheet Metrics
Total Assets
323.7M
Total Liabilities
122.5M
Shareholders Equity
201.2M
Debt to Equity
0.61
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Integrated Proteins Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 215.0M | 2.4M | 1.7M | 0 | 0 |
| Cost of Goods Sold | 210.2M | 2.2M | 1.5M | 0 | 0 |
| Gross Profit | 4.7M | 151.0K | 200.0K | 0 | 0 |
| Gross Margin % | 2.2% | 6.4% | 12.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 624.0K | 208.0K | 433.0K | 454.0K | 548.0K |
| Other Operating Expenses | 2.9M | 521.0K | 596.0K | 188.0K | 255.0K |
| Total Operating Expenses | 3.5M | 729.0K | 1.0M | 642.0K | 803.0K |
| Operating Income | 977.0K | -1.4M | -1.1M | -1.1M | -1.3M |
| Operating Margin % | 0.5% | -61.0% | -68.7% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | 1.5M | 1.6M | 1.6M | 1.6M | 1.6M |
| Interest Expense | 0 | 0 | 0 | 1.0K | 0 |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 3.2M | 1.0M | 419.0K | 493.0K | 286.0K |
| Income Tax | 694.0K | 146.0K | 109.0K | 129.0K | 161.0K |
| Effective Tax Rate % | 21.7% | 14.1% | 26.0% | 26.2% | 56.3% |
| Net Income | 2.5M | 893.0K | 309.0K | 365.0K | 212.0K |
| Net Margin % | 1.2% | 37.6% | 18.5% | 0.0% | 0.0% |
| Key Metrics | |||||
| EBITDA | 2.6M | 378.0K | 707.0K | 782.0K | 574.0K |
| EPS (Basic) | ₹0.71 | ₹0.29 | ₹0.09 | ₹0.10 | ₹0.07 |
| EPS (Diluted) | ₹0.71 | ₹0.25 | ₹0.09 | ₹0.10 | ₹0.07 |
| Basic Shares Outstanding | 3520200 | 3203600 | 3203600 | 3203600 | 3204000 |
| Diluted Shares Outstanding | 3520200 | 3203600 | 3203600 | 3203600 | 3204000 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Integrated Proteins Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 874.0K | 615.0K | 270.0K | 355.0K | 706.0K |
| Short-term Investments | - | - | - | - | 1.0M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | -2.0K | 378.0K | -2.0K | 303.0K | -1.0K |
| Total Current Assets | 323.2M | 993.0K | 681.0K | 674.0K | 978.0K |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 464.0K | 4.2M | 4.1M | 4.4M | 4.7M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | - | - | - | - | - |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 1.0K | 3.3M | 1.0K | 1.0K | 1.0K |
| Total Non-Current Assets | 538.0K | 26.4M | 27.4M | 26.2M | 25.1M |
| Total Assets | 323.7M | 27.4M | 28.1M | 26.9M | 26.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 80.0M | 129.0K | 566.0K | 522.0K | 456.0K |
| Short-term Debt | 39.0M | 0 | 0 | 0 | 0 |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.0K | 15.0K | 16.0K | 12.0K | 5.0K |
| Total Current Liabilities | 122.5M | 829.0K | 814.0K | 931.0K | 858.0K |
| Non-Current Liabilities | |||||
| Long-term Debt | 0 | 350.0K | 1.9M | 798.0K | 344.0K |
| Deferred Tax Liabilities | 0 | 110.0K | 205.0K | 303.0K | 303.0K |
| Other Non-Current Liabilities | -1.0K | 1.0K | -50.0K | -48.0K | - |
| Total Non-Current Liabilities | 0 | 461.0K | 2.1M | 1.1M | 647.0K |
| Total Liabilities | 122.5M | 1.3M | 2.9M | 2.0M | 1.5M |
| Equity | |||||
| Common Stock | 35.2M | 35.2M | 35.2M | 35.2M | 35.2M |
| Retained Earnings | -6.6M | -9.1M | -10.0M | -10.3M | -10.7M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 201.2M | 26.1M | 25.2M | 24.9M | 24.5M |
| Key Metrics | |||||
| Total Debt | 39.0M | 350.0K | 1.9M | 798.0K | 344.0K |
| Working Capital | 200.6M | 164.0K | -133.0K | -257.0K | 120.0K |
Balance Sheet Composition
Integrated Proteins Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 3.2M | 1.0M | 419.0K | 493.0K | 286.0K |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -315.8M | 280.0K | -238.0K | -80.0K | -37.0K |
| Operating Cash Flow | -314.2M | -181.0K | -1.4M | -1.1M | -1.3M |
| Investing Activities | |||||
| Capital Expenditures | 4.3M | 425.0K | 0 | 0 | 0 |
| Acquisitions | - | - | - | - | - |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 4.3M | 425.0K | 0 | 0 | 0 |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | - | - | 1.1M | 454.0K | 344.0K |
| Debt Repayment | -350.0K | -1.6M | - | - | - |
| Financing Cash Flow | 383.8M | -1.6M | 1.1M | 908.0K | 344.0K |
| Free Cash Flow | -235.6M | -594.0K | -1.2M | -925.0K | -922.0K |
| Net Change in Cash | 73.9M | -1.3M | -260.0K | -235.0K | -997.0K |
Cash Flow Trend
Integrated Proteins Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
136.13
Price to Book
1.47
Price to Sales
6.93
PEG Ratio
-1.09
Profitability Ratios
Profit Margin
0.96%
Operating Margin
1.07%
Return on Equity
1.24%
Return on Assets
0.77%
Financial Health
Current Ratio
3.46
Debt to Equity
0.46
Beta
0.07
Per Share Data
EPS (TTM)
₹0.70
Book Value per Share
₹64.76
Revenue per Share
₹78.09
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| INTEGFD | 1.8B | 136.13 | 1.47 | 1.24% | 0.96% | 0.46 |
| Venky's (India | 21.4B | 41.84 | 1.48 | 7.90% | 1.48% | 13.06 |
| Apex Frozen Foods | 15.1B | 45.02 | 2.92 | 0.78% | 3.45% | 7.97 |
| Andrew Yule | 11.2B | 108.71 | 3.10 | -0.84% | 3.56% | 33.31 |
| Dhampur Bio Organics | 7.9B | 33.58 | 0.82 | 1.45% | 1.17% | 58.45 |
| Sharat Industries | 5.8B | 47.12 | 3.84 | 7.28% | 3.27% | 81.98 |
Financial data is updated regularly. All figures are in the company's reporting currency.



